Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Study to Determine the Long Term Safety, Tolerability and Biological Activity of SAR422459 in Patients With Stargardt's Macular Degeneration

NCT01736592 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT01736592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01736592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Study to Determine the Long Term Safety, Tolerability and Biological Activity of SAR422459 in Patients With Stargardt's Macular Degeneration
Lead sponsor
Sanofi
Phase
Phase 2
Overall status
Active, not recruiting
Start date
December 14, 2012
Completion date
August 29, 2033
Enrollment
27 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

stargardt's disease